Repurposing Marketed Drugs as Antidepressants with In Silico, In Vivo, and In Vitro Screening Methods

Area of Science:

• Pharmacology and Computational Chemistry
• Neuroscience and Psychiatry

Background:

• Drug repurposing offers a cost-effective strategy for discovering new therapeutics.
• The increasing understanding of depression pathogenesis necessitates novel treatment approaches.
• Traditional drug discovery faces challenges with slow progress and high costs.

Purpose of the Study:

• To computationally repurpose indole- and isatin-containing drugs for depression treatment.
• To identify potential new therapeutic applications for existing drug compounds.
• To leverage computational methods for accelerating drug discovery in psychiatry.

Main Methods:

• Utilizing computational approaches for drug repurposing.
• Focusing on chemical structures containing indole and isatin moieties.
• Applying bioinformatics and cheminformatics tools for drug screening.

Main Results:

• Identification of specific indole- and isatin-containing compounds with potential antidepressant activity.
• In silico screening of drug candidates against depression-related targets.
• Prioritization of repurposed drugs for further experimental validation.

Conclusions:

• Computational drug repurposing is a viable strategy for identifying novel depression treatments.
• Indole and isatin scaffolds show promise for developing new antidepressant medications.
• This approach can expedite the development of effective therapies for major depressive disorder.